NCT06679985 2026-02-05
A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma
Coherus Oncology, Inc.
Phase 2 Recruiting
Coherus Oncology, Inc.
Shanghai Junshi Bioscience Co., Ltd.
Coherus Oncology, Inc.
Peking Union Medical College Hospital
Henan Cancer Hospital
Sichuan University